Does Brooklyn ImmunoTherapeutics Inc. (AMEX: BTX) Still Look Attractive After A -20.51% Selloff Last Week? – Marketing Sentinel
Home  »  Company   »  Does Brooklyn ImmunoTherapeutics Inc. (AMEX: BTX) ...

Does Brooklyn ImmunoTherapeutics Inc. (AMEX: BTX) Still Look Attractive After A -20.51% Selloff Last Week?

During the last session, Brooklyn ImmunoTherapeutics Inc. (AMEX:BTX)’s traded shares were 1.26 million, with the beta value of the company hitting 4.85. At the end of the trading day, the stock’s price was $9.73, reflecting an intraday gain of 0.93% or $0.09. The 52-week high for the BTX share is $80.67, that puts it down -729.09 from that peak though still a striking 68.14% gain since the share price plummeted to a 52-week low of $3.10. The company’s market capitalization is $521.04M, and the average intraday trading volume over the past 10 days was 1.14 million shares, and the average trade volume was 1.62 million shares over the past three months.

Brooklyn ImmunoTherapeutics Inc. (AMEX:BTX) trade information

Brooklyn ImmunoTherapeutics Inc. (BTX) registered a 0.93% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.93% in intraday trading to $9.73 this Wednesday, 09/22/21, hitting a weekly high. The stock’s 5-day price performance is -20.51%, and it has moved by 1.88% in 30 days. Based on these gigs, the overall price performance for the year is 140.84%. The short interest in Brooklyn ImmunoTherapeutics Inc. (AMEX:BTX) is 1.38 million shares and it means that shorts have 1.08 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

The consensus price target of analysts on Wall Street is $11.00, which implies an increase of 11.55% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $11.00 and $11.00 respectively. As a result, BTX is trading at a discount of -13.05% off the target high and -13.05% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.40%. While earnings are projected to return -110.90% in 2021.

BTX Dividends

Brooklyn ImmunoTherapeutics Inc. is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Brooklyn ImmunoTherapeutics Inc. (AMEX:BTX)’s Major holders

Brooklyn ImmunoTherapeutics Inc. insiders own 44.99% of total outstanding shares while institutional holders control 8.60%, with the float percentage being 15.63%. Blackrock Inc. is the largest shareholder of the company, while 73 institutions own stock in it. As of Jun 29, 2021, the company held over 1.4 million shares (or 2.71% of all shares), a total value of $25.27 million in shares.

The next largest institutional holding, with 0.47 million shares, is of Cypress Point Wealth Management, LLC’s that is approximately 0.91% of outstanding shares. At the market price on Jun 29, 2021, these shares were valued at $8.5 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also, the Mutual Funds coming in first place with the largest holdings of Brooklyn ImmunoTherapeutics Inc. (BTX) shares are iShares Russell 2000 ETF and iShares Russell 2000 Growth ETF. Data provided on Jun 29, 2021 indicates that iShares Russell 2000 ETF owns about 0.54 million shares. This amounts to just over 1.05 percent of the company’s overall shares, with a $9.76 million market value. The same data shows that the other fund manager holds slightly less at 0.16 million, or about 0.32% of the stock, which is worth about $2.97 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam